Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study
- PMID: 17522151
- PMCID: PMC2095419
- DOI: 10.1136/bjo.2006.113670
Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study
Abstract
Background: The excess risk of bilateral visual impairment (BVI; bilateral visual acuity <0.5) among individuals with amblyopia is an argument for screening for amblyopia, but data are scarce.
Methods: The risk was estimated by determining the incidence of BVI in the Rotterdam Study, a population-based cohort of subjects aged 55 years or over (n = 5220), including 192 individuals with amblyopia (3.7%). Using a multistate lifetable, the lifetime risk and excess period spent with BVI were determined.
Results: The relative risk of BVI for amblyopes was 2.6 (95% confidence interval 1.4-4.5). For individuals with amblyopia, the lifetime risk of BVI was 18%, whereas they lived on average 7.2 years with BVI. For non-amblyopic individuals, these figures were 10% and 6.7 years, respectively.
Conclusion: Amblyopia nearly doubles the lifetime risk of BVI and affected individuals spent an extra six months with BVI. This study provides data for future cost-effectiveness analyses.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
The negative impact of amblyopia from a population perspective: untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment.Br J Ophthalmol. 2007 Nov;91(11):1417-8. doi: 10.1136/bjo.2007.122168. Br J Ophthalmol. 2007. PMID: 17947260 Free PMC article.
Similar articles
-
Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration.BMC Ophthalmol. 2016 May 17;16(1):56. doi: 10.1186/s12886-016-0234-0. BMC Ophthalmol. 2016. PMID: 27184381 Free PMC article.
-
The negative impact of amblyopia from a population perspective: untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment.Br J Ophthalmol. 2007 Nov;91(11):1417-8. doi: 10.1136/bjo.2007.122168. Br J Ophthalmol. 2007. PMID: 17947260 Free PMC article.
-
Sensitivity to Velocity- and Disparity-Based Cues to Motion-In-Depth With and Without Spared Stereopsis in Binocular Visual Impairment.Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4375-4383. doi: 10.1167/iovs.17-23692. Invest Ophthalmol Vis Sci. 2018. PMID: 30193309
-
Perceived Visual Distortions in Juvenile Amblyopes During/Following Routine Amblyopia Treatment.Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4045-54. doi: 10.1167/iovs.16-19210. Invest Ophthalmol Vis Sci. 2016. PMID: 27494346
-
Binocular vision therapy for the treatment of Amblyopia-A review.Indian J Ophthalmol. 2023 May;71(5):1797-1803. doi: 10.4103/IJO.IJO_3098_22. Indian J Ophthalmol. 2023. PMID: 37203032 Free PMC article. Review.
Cited by
-
[Amblyopia. Epidemiology, causes and risk factors].Ophthalmologe. 2016 Apr;113(4):283-8. doi: 10.1007/s00347-016-0247-3. Ophthalmologe. 2016. PMID: 27037554 Review. German.
-
Amblyopia Preferred Practice Pattern.Ophthalmology. 2023 Mar;130(3):P136-P178. doi: 10.1016/j.ophtha.2022.11.003. Epub 2022 Dec 14. Ophthalmology. 2023. PMID: 36526450 Free PMC article. No abstract available.
-
Feasibility of a school-based vision screening program to detect undiagnosed visual problems in kindergarten children in Ontario.CMAJ. 2020 Jul 20;192(29):E822-E831. doi: 10.1503/cmaj.191085. CMAJ. 2020. PMID: 32690557 Free PMC article.
-
Elbow splinting as a method to increase patching compliance in amblyopia therapy.Eye (Lond). 2017 Mar;31(3):406-410. doi: 10.1038/eye.2016.222. Epub 2016 Nov 4. Eye (Lond). 2017. PMID: 27813515 Free PMC article.
-
Quality of life during occlusion therapy for amblyopia from the perspective of the children and from that of their parents, as proxy.BMC Ophthalmol. 2022 Mar 25;22(1):135. doi: 10.1186/s12886-022-02342-w. BMC Ophthalmol. 2022. PMID: 35337271 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical